Jen T, Frazee J S, Schwartz M S, Kaiser C
J Med Chem. 1977 Oct;20(10):1258-62. doi: 10.1021/jm00220a600.
In a search for new selective bronchodilators, three 2-pyridylethanolamines, i.e., 2-tert-butylamino-1-(5-hydroxy-2-pyridyl)ethanol (2b), a related 6-methylsulfonylmethyl (2c), and, a 6-methyl (2d) derivative, were prepared. These compounds were examined for potential bronchodilator activity in an in vitro test for relaxation of guinea pig tracheal tissue. Potential cardiac stimulant activity was evaluated in vitro by measuring changes in the rate of spontaneously beating guinea pig right atrial muscle. Comparison of potency in the tracheal test relative to that in the atrial procedure provides a measure of selectivity. Results of this study indicate that replacement of the phenyl ring of a para-hydroxylated phenylethanolamine with a 2-pyridyl system generally results in compounds which retain a high order of potency in the tracheal test; however, selectivity for tracheobronchial vs. cardiac tissue is markedly greater for the pyridyl derivatives. The alpha-picoline, 2-tert-butylamino-1-(5-hydroxy-6-methyl-2-pyridyl) ethanol (2d), which bears labile protons at a position meta to the ethanolamine side chain, was about equipotent with the corresponding 6-unsubstituted relative 2b. The reason for the failure of these apparently appropriately located labile protons to enhance beta-adrenoreceptor agonist activity is uncertain.
为了寻找新型选择性支气管扩张剂,我们制备了三种2-吡啶基乙醇胺,即2-叔丁基氨基-1-(5-羟基-2-吡啶基)乙醇(2b)、一种相关的6-甲基磺酰基甲基衍生物(2c)以及一种6-甲基衍生物(2d)。在豚鼠气管组织舒张的体外试验中检测了这些化合物的潜在支气管扩张活性。通过测量豚鼠右心房肌自发搏动速率的变化在体外评估了潜在的心脏兴奋活性。比较气管试验中的效价与心房试验中的效价可提供选择性的衡量指标。本研究结果表明,用2-吡啶基体系取代对羟基苯乙醇胺的苯环通常会产生在气管试验中保持高效价的化合物;然而,吡啶基衍生物对气管支气管组织与心脏组织的选择性明显更高。α-甲基吡啶,2-叔丁基氨基-1-(5-羟基-6-甲基-2-吡啶基)乙醇(2d),在乙醇胺侧链间位带有不稳定质子,其活性与相应的6-未取代类似物2b相当。这些位置明显合适的不稳定质子未能增强β-肾上腺素能受体激动剂活性的原因尚不确定。